A Novel ATM/TP53/p21-Mediated Checkpoint Only Activated by Chronic γ-Irradiation

• Lili Cao ,

  Contributed equally to this work with: Lili Cao, Hidehiko Kawai

  Affiliations Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Department of Molecular Radiobiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Hidehiko Kawai ,

  Contributed equally to this work with: Lili Cao, Hidehiko Kawai

  * E-mail: kawaih@hiroshima-u.ac.jp

  Affiliation Department of Molecular Radiobiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Megumi Sasatani,

  Affiliation Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Daisuke Iizuka,

  Affiliation Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Yuji Masuda,

  Affiliations Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Department of Genome Dynamics, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Japan

  ⨯
• Toshiya Inaba,

  Affiliation Department of Molecular Oncology & Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Keiji Suzuki,

  Affiliation Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

  ⨯
• Akira Ootsuyama,

  Affiliation Department of Radiation Biology and Health, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

  ⨯
• Toshiyuki Umata,

  Affiliation Radioisotope Research Center, University of Occupational and Environmental Health, Kitakyushu, Japan

  ⨯
• Kenji Kamiya,

  Affiliation Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Fumio Suzuki

  Affiliation Department of Molecular Radiobiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯